Immune Response After Breakthrough Infection or Fourth COVID-19 Vaccine Dose in Cancer Patients
Researchers sought to determine the humoral immune response to the COVID-19 vaccine in patients with cancer after a third or fourth dose of the vaccine or breakthrough infection.